[1]
|
Holl, D.C., Volovici, V., Dirven, C.M.F., Peul, W.C., van Kooten, F., Jellema, K., et al. (2018) Pathophysiology and Nonsurgical Treatment of Chronic Subdural Hematoma: From Past to Present to Future. World Neurosurgery, 116, 402-411.e2. https://doi.org/10.1016/j.wneu.2018.05.037
|
[2]
|
Huang, J., Gao, C., Dong, J., Zhang, J. and Jiang, R. (2020) Drug Treatment of Chronic Subdural Hematoma. Expert Opinion on Pharmacotherapy, 21, 435-444. https://doi.org/10.1080/14656566.2020.1713095
|
[3]
|
Isaji, T., Osuka, K., Ohmichi, Y., Ohmichi, M., Naito, Munekazu, Nakano, T., et al. (2020) Expression of Angiopoietins and Angiogenic Signaling Pathway Molecules in Chronic Subdural Hematomas. Journal of Neurotrauma, 37, 2493-2498. https://doi.org/10.1089/neu.2020.7042
|
[4]
|
Weigel, R., Hohenstein, A., Schlickum, L., Weiss, C. and Schilling, L. (2007) Angiotensin Converting Enzyme Inhibition for Arterial Hypertension Reduces the Risk of Recurrence in Patients with Chronic Subdural Hematoma Possibly by an Antiangiogenic Mechanism. Neurosurgery, 61, 788-792; Discussion 792-793.
https://doi.org/10.1227/01.NEU.0000298907.56012.E8
|
[5]
|
Poulsen, F.R., Munthe, S., Søe, M. and Halle, B, (2014) Perindopril and Residual Chronic Subdural Hematoma Volumes Six Weeks after Burr Hole Surgery: A Randomized Trial. Clinical Neurology and Neurosurgery, 123, 4-8.
https://doi.org/10.1016/j.clineuro.2014.05.003
|
[6]
|
Neidert, M.C., Schmidt, T., Mitova, T., Mitova, T., Fierstra, J., Bellut, D., et al. (2015) Preoperative Angiotensin Converting Enzyme Inhibitor Usage in Patients with Chronic Subdural Hematoma: Associations with Initial Presentation and Clinical Outcome. Journal of Clinical Neuroscience, 28, 82-86. https://doi.org/10.1016/j.jocn.2015.09.022
|
[7]
|
Kageyama, H., Toyooka, T., Tsuzuki, N. and Oka, K. (2013) Nonsurgical Treatment of Chronic Subdural Hematoma with Tranexamic Acid. Journal of neurosurgery, 119, 332-337. https://doi.org/10.3171/2013.3.JNS122162
|
[8]
|
Hunt, B.J. (2015) The Current Place of Tranexamic Acid in the Management of Bleeding. Anaesthesia, 70, 50-e18.
https://doi.org/10.1111/anae.12910
|
[9]
|
Tanweer, O., Frisoli, F.A., Bravate, C., Harrison, G., Pacione, D., Kondziolka, D., et al. (2016) Tranexamic Acid for Treatment of Residual Subdural Hematoma after Bedside Twist-Drill Evacuation. World Neurosurgery, 91, 29-33.
https://doi.org/10.1016/j.wneu.2016.03.062
|
[10]
|
Mikkelsen, R., Anker-Møller, T., Hvas, A.-M. and Sunde, N. (2017) A Case of Tranexamic Acid as Adjunctive Treatment for Chronic Subdural Hematoma with Multiple Recurrences. American Journal of Case Reports, 18, 995-999.
https://doi.org/10.12659/AJCR.904117
|
[11]
|
Lecker, I., Wang, D.-S., Whissell, P.D., Avramescu, S., Mazer, C.D. and Orser, B.A. (2016) Tranexamic Acid-Associated Seizures: Causes and Treatment. Annals of Neurology, 79, 18-26. https://doi.org/10.1002/ana.24558
|
[12]
|
Tamura, K., Sakurai, T. and Kogo, H. (2006) Relationship between Prostaglandin E2 and Vascular Endothelial Growth Factor (VEGF) in Angiogenesis in Human Vascular Endothelial Cells. Vascular Pharmacology, 44, 411-416.
https://doi.org/10.1016/j.vph.2006.02.009
|
[13]
|
Hara, M., Tamaki, M., Aoyagi, M. and Ohno, K. (2009) Possible Role of Cyclooxygenase-2 in Developing Chronic Subdural Hematoma. Journal of Medical and Dental Sciences, 56, 101-106.
|
[14]
|
Liu, Y., Shields, L.B.E., Gao, Z., Wang, Y., Zhang, Y.P., Chu, T., et al. (2017) Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases. Molecular Neurobiology, 54, 5563-5572.
https://doi.org/10.1007/s12035-016-0062-5
|
[15]
|
Hirasima, Y., Endo, S., Kato, R., Ohmori, T., Nagahori, T., Nishijima, M., et al. (1994) Platelet-Activating Factor (PAF) and the Development of Chronic Subdural Haematoma. Acta Neurochirurgica, 129, 20-25.
https://doi.org/10.1007/BF01400868
|
[16]
|
Hirashima, Y., Kuwayama, N., Hamada, H., Hayashi, N. and Endo, S. (2002) Etizolam, an Anti-Anxiety Agent, Attenuates Recurrence of Chronic Subdural Hematoma—Evaluation by Computed Tomography. Neurologia Medico-Chirurgica, 42, 53-56. https://doi.org/10.2176/nmc.42.53
|
[17]
|
Hirashima, Y., Kurimoto, M., Nagai, S., Hori, E., Origasa, H. and Endo, S. (2005) Effect of Platelet-Activating Factor Receptor Antagonist, Etizolam, on Resolution of Chronic Subdural Hematoma. Neurologia Medico-Chirurgica, 45, 621-626. https://doi.org/10.2176/nmc.45.621
|
[18]
|
Frati, A., Salvati, M., Mainiero, F., Ippoliti, F., Rocchi, G., Raco, A., et al. (2004) Inflammation Markers and Risk Factors for Recurrence in 35 Patients with a Posttraumatic Chronic Subdural Hematoma: A Prospective Study. Journal of Neurosurgery, 100, 24-32. https://doi.org/10.3171/jns.2004.100.1.0024
|
[19]
|
Berghauser Pont, L.M.E., Dirven, C.M.F., Dippel, D.W.J., Verweij, B.H. and Dammers, R. (2012) The Role of Corticosteroids in the Management of Chronic Subdural Hematoma: A Systematic Review. European Journal of Neurology, 19, 1397-403. https://doi.org/10.1111/j.1468-1331.2012.03768.x
|
[20]
|
Tang, J., Ai, J. and Macdonald, R.L. (2011) Developing a Model of Chronic Subdural Hematoma. In: Zhang, J. and Colohan, A., Eds., Intracerebral Hemorrhage Research, Vol. 111, Springer, Vienna, 25-29.
https://doi.org/10.1007/978-3-7091-0693-8_5
|
[21]
|
Berghauser Pont, L.M.E., Dammers, R., Schouten, J.W., Lingsma, H.F. and Dirven, C.M.F. (2012) Clinical Factors Associated with Outcome in Chronic Subdural Hematoma: A Retrospective Cohort Study of Patients on Preoperative Corticosteroid Therapy. Neurosurgery, 70, 873-880. https://doi.org/10.1227/NEU.0b013e31823672ad
|
[22]
|
Delgado-López, P.D., Martín-Velasco, V., Castilla-Díez, J.M., Rodríguez-Salazar, A., Galacho-Harriero, A.M. and Fernández-Arconada, O. (2009) Dexamethasone Treatment in Chronic Subdural Haematoma. Neurocirugía, 20, 346-359.
https://doi.org/10.1016/S1130-1473(09)70154-X
|
[23]
|
Zhang, Y.M., Chen, S.P., et al. (2017) Effects of Dexamethasone in the Treatment of Recurrent Chronic Subdural Hematoma. World Neurosurgery, 105, 115-121. https://doi.org/10.1016/j.wneu.2017.05.135
|
[24]
|
Sun, T.F.D., Boet, R. and Poon, W.S. (2005) Non-Surgical Primary Treatment of Chronic Subdural Haematoma: Preliminary Results of Using Dexamethasone. British Journal of Neurosurgery, 19, 327-333.
https://doi.org/10.1080/02688690500305332
|
[25]
|
Miah, I.P., Herklots, M., Roks, G., Peul, W.C., Walchenbach, R., Dammers, R., et al. (2020) Dexamethasone Therapy in Symptomatic Chronic Subdural Hematoma (DECSA-R): A Retrospective Evaluation of Initial Corticosteroid Therapy versus Primary Surgery. Journal of Neurotrauma, 37, 366-372. https://doi.org/10.1089/neu.2019.6541
|
[26]
|
Quan, W., Zhang, Z., Li, P., Tian, Q., Huang, J., Qian, Y., et al. (2019) Role of Regulatory T Cells in Atorvastatin Induced Absorption of Chronic Subdural Hematoma in Rats. Aging and Disease, 10, 992-1002.
https://doi.org/10.14336/ad.2018.0926
|
[27]
|
van der Veeken, J., Gonzalez, A.J., Cho, H., Arvey, A., Hemmers, S., Leslie, C.S., et al. (2016) Memory of Inflammation in Regulatory T Cells. Cell, 166, 977-990. https://doi.org/10.1016/j.cell.2016.07.006
|
[28]
|
Jiang, R., Zhao, S., Wang, R., Feng, H., Zhang, J., Li, X., et al. (2018) Safety and Efficacy of Atorvastatin for Chronic Subdural Hematoma in Chinese Patients: A Randomized Clinical Trial. JAMA Neurology, 75, 1338-1346.
https://doi.org/10.1001/jamaneurol.2018.2030
|
[29]
|
Wang, D., Li, T., Tian, Y., Wang, S., Jin, C., Wei, H., et al. (2014) Effects of Atorvastatin on Chronic Subdural Hematoma: A Preliminary Report from Three Medical Centers. Journal of the Neurological Sciences, 336, 237-242.
https://doi.org/10.1016/j.jns.2013.11.005
|
[30]
|
Xu, M., Chen, P., Zhu, X., Wang, C., Shi, X. and Yu, B. (2016) Effects of Atorvastatin on Conservative and Surgical Treatments of Chronic Subdural Hematoma in Patients. World Neurosurgery, 91, 23-28.
https://doi.org/10.1016/j.wneu.2016.03.067
|
[31]
|
Wang, D., Gao, C., Xu, X., Chen, T., Tian, Y., Wei, H., et al. (2020) Treatment of Chronic Subdural Hematoma with Atorvastatin Combined with Low-Dose Dexamethasone: Phase II Randomized Proof-of-Concept Clinical Trial. Journal of Neurosurgery JNS, 134, 235-243. https://doi.org/10.3171/2019.11.JNS192020
|
[32]
|
Song, Y., Wang, Z., Liu, L., Wang, D. and Zhang, J. (2013) The Level of Circulating Endothelial Progenitor Cells May Be Associated with the Occurrence and Recurrence of Chronic Subdural Hematoma. Clinics, 68, 1084-1088.
https://doi.org/10.6061/clinics/2013(08)04
|
[33]
|
Fan, Y., Wang, D., Rao, C., Rong, H., Li, Y., Wang, Z., et al. (2020) Atorvastatin Combined with Low-Dose Dexamethasone Treatment Protects Endothelial Function Impaired by Chronic Subdural Hematoma via the Transcription Factor KLF-2. Drug Design, Development and Therapy, 14, 3291-3299. https://doi.org/10.2147/DDDT.S256050
|